ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.89
0.70%
US Tech 100
18,062.00
-0.10%
S&P 500
5,303.27
0.12%
US Dollar vs CAD
1.36165
-0.01%
Bitcoin
66,986.37
-0.14%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Abraxis Bioscience (MM) (ABBI)

  7. Abraxis Bioscience (MM) (ABBI) News

ABBI

Abraxis Bioscience (MM) (ABBI)

Abraxis Bioscience (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ABBI
DateTimeSourceHeadlineSymbolCompany
11/12/20088:00AMPR Newswire (US)Deloitte Names Abraxis BioScience Inc. Fastest Growing Technology Company in Los Angeles AreaNASDAQ:ABBIAbraxis Bioscience (MM)
11/12/20087:00AMPR Newswire (US)Deloitte Unveils 2008 Technology Fast 500 RankingNASDAQ:ABBIAbraxis Bioscience (MM)
11/13/20074:02PMEdgar (US Regulatory)Abraxis Bioscience, Inc. (Other) (S-8 POS)NASDAQ:ABBIAbraxis Bioscience (MM)
11/13/20074:01PMEdgar (US Regulatory)Abraxis Bioscience, Inc. (Other) (S-8 POS)NASDAQ:ABBIAbraxis Bioscience (MM)
11/13/20074:00PMEdgar (US Regulatory)Abraxis Bioscience, Inc. (Other) (S-8 POS)NASDAQ:ABBIAbraxis Bioscience (MM)
11/13/20073:55PMEdgar (US Regulatory)Abraxis Bioscience, Inc. (Other) (S-8 POS)NASDAQ:ABBIAbraxis Bioscience (MM)
11/13/20073:55PMEdgar (US Regulatory)Abraxis Bioscience, Inc. (Other) (POSASR)NASDAQ:ABBIAbraxis Bioscience (MM)
11/13/200710:19AMEdgar (US Regulatory)Abraxis Bioscience, Inc. (Other) (8-K)NASDAQ:ABBIAbraxis Bioscience (MM)
11/08/200710:03AMEdgar (US Regulatory)Abraxis Bioscience, Inc. - Current report filing (8-K)NASDAQ:ABBIAbraxis Bioscience (MM)
11/05/20073:58PMEdgar (US Regulatory)Abraxis Bioscience, Inc. - Prospectus filed pursuant to Rule 424(b)(7) (424B7)NASDAQ:ABBIAbraxis Bioscience (MM)
10/30/20073:23PMEdgar (US Regulatory)Abraxis Bioscience, Inc. - Statement of Changes in Beneficial Ownership (4)NASDAQ:ABBIAbraxis Bioscience (MM)
10/30/20073:23PMEdgar (US Regulatory)Abraxis Bioscience, Inc. - Statement of Changes in Beneficial Ownership (4)NASDAQ:ABBIAbraxis Bioscience (MM)
10/30/20073:22PMEdgar (US Regulatory)Abraxis Bioscience, Inc. - Amended Statement of Changes in Beneficial Ownership (4/A)NASDAQ:ABBIAbraxis Bioscience (MM)
10/30/20073:22PMEdgar (US Regulatory)Abraxis Bioscience, Inc. - Amended Statement of Changes in Beneficial Ownership (4/A)NASDAQ:ABBIAbraxis Bioscience (MM)
08/10/20077:05AMBusiness WireAPP Receives Expedited Approval for the First and Only Generic Cefotetan Disodium for InjectionNASDAQ:ABBIAbraxis Bioscience (MM)
08/09/20077:50PMBusiness WireAbraxis BioScience Files Information Statement in Connection with Its Announced Separation into Two Publicly Traded CompaniesNASDAQ:ABBIAbraxis Bioscience (MM)
08/09/20077:05AMBusiness WireAbraxis BioScience Reports Second Quarter 2007 Revenue of $243 Million versus $161 Million in Prior Year PeriodNASDAQ:ABBIAbraxis Bioscience (MM)
08/08/20079:35PMBusiness WireAbraxis BioScience Announces Licensing Agreement with Biocon Limited for the Commercialization of ABRAXANE in IndiaNASDAQ:ABBIAbraxis Bioscience (MM)
08/08/20075:20PMBusiness WireAbraxis BioScience Launches Doxorubicin Hydrochloride Injection, USPNASDAQ:ABBIAbraxis Bioscience (MM)
08/07/20077:00AMBusiness WireAbraxis BioScience Receives FDA Approval for Oxytocin Injection 10 USP Units/mL in a 30 mL VialNASDAQ:ABBIAbraxis Bioscience (MM)
08/06/20073:15PMBusiness WireAbraxis BioScience Receives Final Approval for Fosphenytoin Sodium Injection, USPNASDAQ:ABBIAbraxis Bioscience (MM)
08/06/20077:00AMBusiness WireAbraxis BioScience Acquires from the Buck Institute Exclusive Worldwide Intellectual Property Rights for Technologies Designed tNASDAQ:ABBIAbraxis Bioscience (MM)
08/02/20075:55PMBusiness WireAbraxis BioScience Receives FDA Approval for Caffeine Citrate Injection USP, 20 mg/mLNASDAQ:ABBIAbraxis Bioscience (MM)
07/31/20073:45PMBusiness WireAbraxis BioScience Acquires Manufacturing Facility from WatsonNASDAQ:ABBIAbraxis Bioscience (MM)
07/26/20077:00AMBusiness WireAbraxis BioScience and the California NanoSystems Institute Announce Partnership for Collaborative Research in the Development oNASDAQ:ABBIAbraxis Bioscience (MM)
07/19/20073:05PMBusiness WireAbraxis BioScience and Biocon Limited Announce Licensing Agreement for G-CSF in North America and the European UnionNASDAQ:ABBIAbraxis Bioscience (MM)
07/16/20073:05PMBusiness WireAbraxis BioScience Announces Date for Second Quarter Financial Results and Investor Conference CallNASDAQ:ABBIAbraxis Bioscience (MM)
07/02/20076:05AMBusiness WireAbraxis BioScience Announces Plan to Separate Into Two Independent Public CompaniesNASDAQ:ABBIAbraxis Bioscience (MM)
06/19/20077:00AMBusiness WireAbraxis BioScience Exclusively Licenses Intellectual Property Portfolio Designed to Personalize Treatment for Colorectal CancerNASDAQ:ABBIAbraxis Bioscience (MM)
06/07/20077:00AMBusiness WireAbraxis BioScience to Present at the Goldman Sachs 28th Annual Global Healthcare ConferenceNASDAQ:ABBIAbraxis Bioscience (MM)
 Showing the most relevant articles for your search:NASDAQ:ABBI

Your Recent History

COIN
XENBTC
EU
VDRAH
Ville De Rennes 0.464% 1...
NYSE
USPAC
Unified Series T
EU
EGR
Transition Evergreen
LSE
0GKL
COIN
CYFMUST
CyberFM
TSXV
GYG
COIN
4ARTUSD
4ArtCoin
NASDAQ
GECCN
Great Elm Capital
KUCN
SUSDETH
Synth sUSD
BITMOT
934502
Ebrd Tf 6,75% Gn25 Huf
GDAX
APEUSD
ApeCoin
COIN
Q2CGBP
COIN
PDRYUSD
PandroytyToken
XE
CP3S
Leverage Shares Public
LSE
CECU
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved